Literature DB >> 11349787

Dynamic locomotor function in normals and patients with vertigo.

K Ishikawa1, Z W Cao, Y Wang, W H Wong, T Tanaka, S Miyazaki, I Toyoshima.   

Abstract

Gait analysis was performed in patients with various vestibular systems using a tactile sensor. There were 4 patients with vestibular neuronitis, 6 patients with large acoustic neuroma and 6 patients with spino-cerebellar degeneration (SCD). Gait phase related parameters such as stance, swing and double support were studied to assess gait stability. Also the area ratio of trajectories of center of force during stance and progression of foot pressure were checked. The calculated value of each variable became high in pathological cases compared with normal controls, and the highest value was obtained in the SCD group. As regards the effect of visual deprivation on stability of gait, the most striking change was found in the large acoustic neuroma group. In a case with a unilateral lesion such as vestibular neuronitis and large acoustic neuroma, foot pressure was greater on the lesion side, especially during gait with eyes closed. As for the foot pressure progression curve, the SCD group showed the most irregular pattern in general, although there were some individual variations. Those results could reflect a functional disorder of the gait control system caused by each disease. Significance of gait analysis is also discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11349787     DOI: 10.1080/000164801300043668

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Dual task interference during gait in patients with unilateral vestibular disorders.

Authors:  Alberto Nascimbeni; Andrea Gaffuri; Arminio Penno; Mara Tavoni
Journal:  J Neuroeng Rehabil       Date:  2010-09-20       Impact factor: 4.262

2.  Tai Chi and vestibular rehabilitation improve vestibulopathic gait via different neuromuscular mechanisms: preliminary report.

Authors:  Chris A McGibbon; David E Krebs; Stephen W Parker; Donna M Scarborough; Peter M Wayne; Steven L Wolf
Journal:  BMC Neurol       Date:  2005-02-18       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.